|
|
"Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C
|
Z01 CP010153
|
$696,133
|
$526,428
|
Ward
|
DCEG (NCI)
|
|
|
"Infections, immunity, and inflammation in cancer"
|
Z01 CP010150
|
$726,292
|
$51,068
|
Engels
|
DCEG (NCI)
|
|
|
(CRCL) vaccine for Chronic Myelogenous Leukemia
|
5R01CA104926-04
|
$264,158
|
$264,158
|
KATSANIS, EMMANUEL
|
UNIVERSITY OF ARIZONA
|
|
|
A computer aided chromosome imaging technique for cancer diagnosis
|
5R01CA115320-02
|
$309,600
|
$185,760
|
Liu, Hong
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
|
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
|
5R01CA107300-04
|
$270,281
|
$135,141
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
|
1R01CA129974-01A1
|
$324,900
|
$324,900
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
Z01 SC 010356
|
$275,874
|
$137,937
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
2R01CA055577-14
|
$264,061
|
$264,061
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
AbI-Abi signaling in neoplastic hematopoiesis
|
5R01CA094921-06
|
$243,183
|
$243,183
|
DAI, ZONGHAN
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-32S1
|
$215,193
|
$10,760
|
THOMPSON, CRAIG
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-32
|
$7,282,327
|
$364,116
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
$445,205
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
3R01CA085915-07S1
|
$51,498
|
$25,749
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
5R01CA085915-07
|
$312,066
|
$156,033
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
1R01CA124782-01A1
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Adult Leukemia Research Center
|
2P01CA018029-32
|
$5,086,500
|
$5,086,500
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
|
5R01CA128609-02
|
$298,169
|
$298,169
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
|
Allogeneic lymphocyte infusions to treat myeloid cancers
|
5R21CA121588-02
|
$282,657
|
$282,657
|
FUCHS, EPHRAIM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Alpha-Particle Immunotherapy of Cancer
|
5R01CA055349-15
|
$389,561
|
$389,561
|
SCHEINBERG, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Alternative Entry Mechanism for Pathogenic Retroviruses
|
5R01CA104266-04
|
$259,594
|
$259,594
|
CUNNINGHAM, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Analysis of a murine model of the AML1-ETO translocation
|
5R01CA096798-04
|
$281,848
|
$281,848
|
KLUG, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Analysis of Intracellular Drug Sequestration
|
5R01CA106655-03
|
$205,489
|
$205,489
|
KRISE, JEFFREY
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,395,646
|
$139,565
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
Angiogenesis and Tumor Growth
|
Z01 SC 010355
|
$551,748
|
$137,937
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
|
Z01 BC 010647
|
$292,262
|
$146,131
|
Rader, Christoph
|
CCR (NCI)
|
|
|
Antibody V Gene Expression B Cell Lymphocytic Leukemia
|
5R37CA049870-20
|
$329,612
|
$329,612
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Antigen Presenting Cells in the Induction of GVHD
|
5R01CA102464-04
|
$277,278
|
$277,278
|
EMERSON, STEPHEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Antileukemic effort of NK cells in HCT for pediatric AML
|
1R01CA120583-01A2
|
$359,055
|
$359,055
|
LEUNG, WING
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
ANTINEOPLASTIC v LEUKEMOGENIC EPIPODOPHYLLOTOXIN EFFECTS
|
5R01CA077683-08
|
$266,610
|
$266,610
|
Felix, Carolyn
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
5R37CA044848-21
|
$360,308
|
$144,123
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
AP-1 Complexes and Target Gene Regulation
|
5R01CA114381-02
|
$256,507
|
$256,507
|
TAPAROWSKY, ELIZABETH
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$3,633
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$1,132
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
$3,279
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
$882
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
$41,244
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arsenic Trioxide Activaed Pathways in APL
|
5R01CA121192-02
|
$260,253
|
$260,253
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY
|
|
|
Arsenic Trioxide in Primary Curative APL Therapy
|
5R01CA100904-04
|
$419,060
|
$419,060
|
GORE, STEVEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Asparagine Synthetase as a Biomarker for L-asparaginase Rx of Ovarian Cancer
|
Z01 BC 010823
|
$303,024
|
$30,302
|
Weinstein, John
|
CCR (NCI)
|
|
|
Aspartame Intake and the Risk of Cancer
|
1R03CA130054-01
|
$116,101
|
$38,313
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Assaying Tyrosine Kinase Activity: A New Paradigm
|
7R33CA105514-04
|
$310,218
|
$310,218
|
SIMS, CHRISTOPHER
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Assays for Screening Histone Modification in Cancer
|
5R01CA107106-04
|
$223,262
|
$223,262
|
FREITAS, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
Assessment of Clinical Retinoid Activity in Leukemia
|
5R01CA056771-15
|
$379,637
|
$379,637
|
GALLAGHER, ROBERT
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
|
Atlanta Regional Community Clinical Oncology Program
|
5U10CA045450-21
|
$623,000
|
$6,230
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
|
BAALC in neurogenesis and hematopoiesis
|
5R01CA098933-04
|
$290,595
|
$145,298
|
DE LA CHAPELLE, ALBERT
|
OHIO STATE UNIVERSITY
|
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
Z01 BC 010856
|
$12,047,693
|
$1,204,769
|
Custer, Mary
|
CCR (NCI)
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$28,800
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Bayesian Models for Gene Expression with Microarray Data
|
5R01CA104620-03
|
$272,472
|
$43,596
|
MALLICK, BANI
|
TEXAS A&M UNIVERSITY SYSTEM
|
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$5,585
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Total relevant funding to Leukemia for this search: $205,535,584
|
